Resources

This resource provides clinical advice from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding the use of vaccines for pregnant women.

This resource provides clinical advice to support changes to the vaccines given at 12 and 18 months through the National Immunisation Program from 1 July 2018.

This document contains the process for developing and reviewing the Public Health Laboratory Network (PHLN) laboratory case definitions.

Learn about how the National Cervical Screening Program is monitored to ensure it continues as a high-quality program and reduces illness and death from cervical cancer.

BreastScreen Australia services and State Coordination Units (SCUs) use this form to report adverse events to the National Quality Management Committee (NQMC).

This document outlines data considerations relevant to Australian Influenza Surveillance Reports (AISRs) from the 2018 and 219 influenza seasons.

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Diagnostic Imaging Clinical Committee's Knee Imaging report.

The BMTP helps patients access international haemopoietic progenitor cell (HPC) donors for transplants. Use this form to apply for funding under the BMTP.

This guidance from the Environmental Health Standing Committee (enHealth) looked at the health impacts of environmental noise to support policy and regulation in Australia.research.

Australian Government response to the Senate Community Affairs References Committee interim report: Effectiveness of the aged care quality assessment and accreditation framework

A summary of the major items discussed at the fourth MDAF meeting.

This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government on its review of neurology and neurosurgery.

The Indigenous Australians’ Health Programme (IAHP) funds comprehensive primary health care services. This report provides insight into the program’s efficiency and return on investment.

This agreement between the Government and Medicines Australia (MA) facilitates cooperation between them to ensure the future sustainability of the Life Saving Drugs Program.

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Dermatology, Allergy and Immunology Clinical Committee report.

The Accessibility Action Plan sets out how we will work together to build and strengthen our culture. We want to be an employer of choice for people with disability and those who care for people with disability.

The Newborn Bloodspot Screening National Policy Framework guides the national policies needed to support the ongoing success of newborn bloodspot screening in Australia.

This report summarises the result of consultations about wellness and reablement approaches in the aged home care sector, which Nous Group held in 2017.

This framework outlines how information in My Health Record can and cannot be used for research, policy and planning purposes. My Health Record data will be used to provide insights into the effectiveness of services and treatments to help us improve Australia's health system.

This report includes recommendations from the Eating Disorder Working Group, which the Medicare Benefits Schedule (MBS) Review Taskforce revised and endorsed following consultation with stakeholders.

This report includes recommendations from the Oncology Clinical Committee, which the Medicare Benefits Schedule (MBS) Review Taskforce revised and endorsed following consultation with stakeholders.

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Spinal Surgery Clinical Committee report.

This summary of the Medical Technology, Biotechnology and Pharmaceutical (MTP) Sector growth plan includes a profile of the current sector, the growth plan and the future outlook.

BreastScreen Australia services and State Coordination Units (SCUs) use this form to record the Service and/or SCU’s performance against those NAS Measures in which they are responsible for. It must be submitted as part of an application for accreditation.

The Health Portfolio Budget Statements for the 2018 to 2019 financial year outline how the Government has allocated resources to outcomes for all entities within our portfolio.